THE EPITHELIAL TUMOR METABOLISM FEATURES DURING ITS MESENCHYMAL TRANSITION
Abstract and keywords
Abstract (English):
The epithelial tumors of various localizations are capable of producing reactive oxygen species that stimulate their epithelial-mesenchymal transformation. For tumors of non-small cell lung cancer (NSCLC), gastric and intestinal adenocarcinomas (GIAC) their metabolic heterogeneity was established. By the results of analysis in morphologically homogeneous tumors of the same localization we detected clusters of tumors characterized by increased activity of xanthine oxidase, superoxide dismutase, decreased activity of glutathione peroxidase (negative relation with pathology (ρ = -0,465, p < 0,05)). Thus, glutathione peroxidase activity was minimal in the second GIAC cluster, 1.4-fold lower, and 1.8-fold lower in their first cluster than in NSCLC tumors of the corresponding clusters. In the second NSCLC cluster, it was 1.5-fold lower than in their first cluster. Against this background, superoxide dismutase activity in tumors of different localizations included in the second clusters, on the contrary, increased 2-fold in NSCLC and 1.7-fold in GIAC, respectively. It leads to increased production of hydrogen peroxide in the tumor. Increase of adenosine deaminase activity detected (positive strong correlation (Spearman rank correlation coefficient ρ = 0,805, p < 0.01)) may be accompanied by a decrease of adenosine levels and its regulatory effects preventing tumor aggressive properties. Correlation of enzymatic activity with pathology was established. In different localization tumors the possibility of metabolic stimulation of tumor epithelial-mesenchymal transformation was revealed.

Keywords:
enzymes, reactive oxygen species, epithelial tumors
Text
Publication text (PDF): Read Download
References

1. Liu J., Qu L., Meng L., Shou C. Topoisomerase Inhibitors Promote Cancer Cell Motility via ROS-Mediated Activation of JAK2-STAT1-CXCL1 Pathway. J. Exp. Clin Cancer Res, 2019, vol. 38, no. 1, pp. 370-375, doi:https://doi.org/10.1186/s13046-019-1353-2.

2. Vasilenko I.V., Kondratyk R.B., Grekov I.S., Yarkov A.M. Epithelial-mesenchymal transition in main types of gastric carcinoma. Clin. Exp Morphol, 2021, vol. 10, no. 2, pp. 13-20, doi: 10.31088/ CEM2021.10.2.13-20.

3. Kumari S., Badana A.K., G M.M., Shailender G., Malla R.R. Reactive oxygen species: a key constituent in cancer survival. Biomark Insights, 2018, vol. 13, pp. 1-9, doi:https://doi.org/10.1177/1177271918755391.

4. Li W., Cao L., Han L., Xu Q., Ma Q. Superoxide dismutase promotes the epithelial-mesenchymal transition of pancreatic cancer cells via activation of the H2O2/ERK/NF-κB axis. Int J Oncol, 2015, vol. 46, no. 6, pp. 2613-2620, doi:https://doi.org/10.3892/ijo.2015.2938.

5. Bakurova E.M. The Energy Metabolom of Red Blood Cells Features in Patients with Advanced Tumors. Modern Trends in Biological Physics and Chemistry. BPPC-2016: Proceedings of XI International Science-Technical Conference, Sevastopol, 25-29 of April, 2016, vol. 2, Sevastopol: Sevastopol State University, 2016, 226 p. (In Russ.)

6. Zuikov S.A., Bakurova E.M., Tursunova Y.D., Khomutov E.V. Increasing the activity of purine catabolism enzymes as one of the pathogenesis factors of malignant neoplasms. Neoplasm, 2021, vol. 13, no. 2 (33), pp. 86-90. (In Russ.)

7. Zeng J., Li M., Xu J.-Y., Xiao H., Yang X., Fan J-X., Wu K., Chen Sh. Aberrant ROS mediate cell cycle and motility in colorectal cancer cells through an oncogenic CXCL14 signaling pathway. Front Pharmacol, 2021, no. 12, doi:https://doi.org/10.3389/fphar.2021.764015.

8. Bakurova E.M., Vasilenko I.V., Tursunova Yu.D., Dobaeva N.M., Borzenko B.G., Yelsky V.N. The features of enzymes activity to nucleoside and antioxidant systems in solid tumors. Russian Journal of Biotherapy, 2022, vol. 21, no. 2, pp. 73-81, doi:https://doi.org/10.17650/1726-9784-2022-21-2-73-81. (In Russ.)


Login or Create
* Forgot password?